Hyperalgesia Global Clinical Trials Review, H1, 2015

Hyperalgesia Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2575CTIDB
  • |
  • Pages: 69
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hyperalgesia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hyperalgesia Global Clinical Trials Review, H1, 2015" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Hyperalgesia 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Central and South America 13

Clinical Trials by G7 Countries: Proportion of Hyperalgesia to Central Nervous System Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Hyperalgesia to Central Nervous System Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Unaccomplished Trials of Hyperalgesia 24

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Hyperalgesia Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Pfizer Inc. 31

Clinical Trial Overview of Pfizer Inc. 31

GlaxoSmithKline plc 32

Clinical Trial Overview of GlaxoSmithKline plc 32

Air Liquide S.A. 33

Clinical Trial Overview of Air Liquide S.A. 33

Raptor Pharmaceuticals Corp. 34

Clinical Trial Overview of Raptor Pharmaceuticals Corp. 34

Pharmed Holding GmbH 35

Clinical Trial Overview of Pharmed Holding GmbH 35

PainCeptor Pharma Corporation 36

Clinical Trial Overview of PainCeptor Pharma Corporation 36

IBSA Institut Biochimique SA 37

Clinical Trial Overview of IBSA Institut Biochimique SA 37

H. Lundbeck A/S 38

Clinical Trial Overview of H. Lundbeck A/S 38

AstraZeneca PLC 39

Clinical Trial Overview of AstraZeneca PLC 39

Clinical Trial Overview of Top Institutes / Government 40

Medical University of Vienna 40

Clinical Trial Overview of Medical University of Vienna 40

Rigshospitalet 41

Clinical Trial Overview of Rigshospitalet 41

Massachusetts General Hospital 42

Clinical Trial Overview of Massachusetts General Hospital 42

University Hospital, Bordeaux 43

Clinical Trial Overview of University Hospital, Bordeaux 43

Yonsei University 44

Clinical Trial Overview of Yonsei University 44

National Institute of Dental and Craniofacial Research 45

Clinical Trial Overview of National Institute of Dental and Craniofacial Research 45

Johns Hopkins University 46

Clinical Trial Overview of Johns Hopkins University 46

University of Washington 47

Clinical Trial Overview of University of Washington 47

University of Zurich 48

Clinical Trial Overview of University of Zurich 48

Seoul National University Hospital 49

Clinical Trial Overview of Seoul National University Hospital 49

Five Key Clinical Profiles 50

Appendix 67

Abbreviations 67

Definitions 67

Research Methodology 68

Secondary Research 68

About GlobalData 69

Contact Us 69

Disclaimer 69

Source 69

List of Figures

Hyperalgesia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Hyperalgesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hyperalgesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hyperalgesia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Hyperalgesia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Hyperalgesia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Hyperalgesia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 14

Hyperalgesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Hyperalgesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Hyperalgesia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 17

Hyperalgesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Hyperalgesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Hyperalgesia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20

Hyperalgesia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21

Hyperalgesia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Hyperalgesia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Hyperalgesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Hyperalgesia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Hyperalgesia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Hyperalgesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Hyperalgesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 68

List of Tables

Hyperalgesia Therapeutics, Global, Clinical Trials by Region, 2015* 7

Hyperalgesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hyperalgesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hyperalgesia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Hyperalgesia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Hyperalgesia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Hyperalgesia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13

Proportion of Hyperalgesia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 14

Hyperalgesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Hyperalgesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Hyperalgesia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 17

Hyperalgesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Hyperalgesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Hyperalgesia Therapeutics, Global, Clinical Trials by Phase, 2015* 20

Hyperalgesia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21

Hyperalgesia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Hyperalgesia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Hyperalgesia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24

Hyperalgesia Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Hyperalgesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Hyperalgesia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Hyperalgesia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Hyperalgesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Hyperalgesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 31

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 32

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Air Liquide S.A., 2015* 33

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Raptor Pharmaceuticals Corp., 2015* 34

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmed Holding GmbH, 2015* 35

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by PainCeptor Pharma Corporation, 2015* 36

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by IBSA Institut Biochimique SA, 2015* 37

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2015* 38

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 39

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 40

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2015* 41

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 42

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2015* 43

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2015* 44

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Dental and Craniofacial Research, 2015* 45

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2015* 46

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 47

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2015* 48

Hyperalgesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Hyperalgesia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hyperalgesia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 162350
Site License
USD 5000 INR 324700
Corporate User License
USD 7500 INR 487050

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com